| W. Berry Maultsby, Jr., O.d., P.c. | |
|
413 Mt. Cross Road, Suite 203, Danville, VA 24540 | |
| (434) 791-3937 | |
| (434) 791-2468 |
| Full Name | W. Berry Maultsby, Jr., O.d., P.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 413 Mt. Cross Road, Danville, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134354897 | NPI | - | NPPES |
| 465270 | Other | ANTHEM | |
| 010337861 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0618000688 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| W. Berry Maultsby, Jr., O.d., P.c. 413 Mt. Cross Road, Suite 203, Danville, VA 24540 Ph: (434) 791-3937 | W. Berry Maultsby, Jr., O.d., P.c. 413 Mt. Cross Road, Suite 203, Danville, VA 24540 Ph: (434) 791-3937 |
News Archive
UCLA researchers found that an experimental cancer drug improves the signs of progeria in a mouse model. Progeria is a rare genetic disease causing accelerated aging and cardiovascular disease in children. The new UCLA findings help to define a new strategy for treating children with progeria.
Last summer, SLU scientists made a breakthrough discovery about the way in which blood clots. Through X-ray crystallography, they solved the molecular structure of prothrombin, an important blood-clotting protein, revealing an unexpected, flexible role for a "linker" region that may be the key to developing better life-saving drugs.
Nowadays, much emphasis is placed on sustainability. The degree to which people are willing to donate their own money for this depends on their level of oxytocin. Scientists at the University of Bonn Hospital have discovered that the willingness to donate increases with the quantity of this bonding hormone. However, oxytocin only has an effect with regard to social sustainability projects. The hormone does not increase the ability to participate in the case of purely environmentally oriented projects.
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
› Verified 6 days ago
Central Vision, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 625 Piney Forest Rd, Suite 208, Danville, VA 24540 Phone: 434-797-2606 Fax: 434-797-2606 | |
Dr. Stephanie Sonnenburg, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 125 Executive Dr Ste E, Danville, VA 24541 Phone: 434-385-5600 | |
Friedrichs Family Eye Center Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 123 Deer Run Rd, Danville, VA 24540 Phone: 434-793-6912 Fax: 434-799-8641 | |
Dominion Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 800 Memorial Dr, Suite A, Danville, VA 24541 Phone: 434-799-3232 Fax: 434-792-5125 | |
Dr. Waiyen Chin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 625 Piney Forest Rd, Suit 208, Danville, VA 24540 Phone: 434-797-2606 Fax: 434-797-2606 | |
John E Crews, OD Optometrist Medicare: Medicare Enrolled Practice Location: 800 Memorial Dr, Suite A, Danville, VA 24541 Phone: 434-799-3232 Fax: 434-792-5125 |